首页 | 本学科首页   官方微博 | 高级检索  
     


Quality of life in patients with K‐RAS wild‐type colorectal cancer
Authors:Jolie Ringash MD  Heather‐Jane Au MD  Lillian L. Siu MD  Jeremy D. Shapiro MD  Derek J. Jonker MD  John R. Zalcberg MD  Malcolm J. Moore MD  Andrew Strickland MD  Rami Kotb MD  Mark Jeffery MD  Thierry Alcindor MD  Siobhan Ng MD  Muhammad Salim MD  Sabe Sabesan MD  Jay C. Easaw MD  Jenny Shannon MD  Fabyolla El‐Tahche PhD  Ian Walters MD  Dongsheng Tu PhD  Christopher J. O'Callaghan DVM  NCIC Clinical Trials Group  Australasian Gastrointestinal Trials Group
Affiliation:1. Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada;2. Cross Cancer Institute, Edmonton, Alberta, Canada;3. Cabrini Hospital and Monash University, Melbourne, Victoria, Australia;4. The Ottawa Hospital and the University of Ottawa, Ottawa, Ontario, Canada;5. Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia;6. Monash Medical Centre and Monash University, Melbourne, Victoria, Australia;7. Sherbrooke University Medical Center, Sherbrooke, Quebec, Canada;8. Christchurch Hospital, Christchurch, South Island, New Zealand;9. McGill University, Montreal General Hospital, Montreal, Quebec, Canada;10. St John of God Hospital, Subiaco, Western Australia, Australia;11. Allan Blair Cancer Centre, Regina, Saskatchewan, Canada;12. Townsville Hospital, Townsville, Queensland, Australia;13. Tom Baker Cancer Centre, Calgary, Alberta, Canada;14. Nepean Hospital, Sydney, New South Wales, Australia;15. National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia;16. Bristol‐Myers Squibb, Wallingford, Connecticut;17. NCIC Clinical Trials Group, Queen's University, Kingston, Ontario, Canada
Abstract:
Keywords:colorectal cancer  K‐RAS  palliative chemotherapy  quality of life  questionnaires  patient‐reported outcomes
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号